Drug Trial Radar · NCT05929066
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Last checked: Nov 20, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,335
Actual
Start
Jul 10, 2023
Primary completion
Apr 6, 2026
Study completion Apr 30, 2026
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Jul 3, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of retatrutide in participants who have obesity or overweight (J1I-MC-GZBJ master protocol) including subsets of participants who have knee osteoarthritis (OA) (J1I-MC-GOA1) or who have obstructive sleep apnea (OSA) (J1I-MC-GSA1). This study will last about 89 weeks and will include up to 24 visits. Addendum (2) is optional and available to approximately 500 participants to continue treatment with retatrutide for up to an additional 24 weeks.
Conditions
- Obesity
- Overweight
- Osteoarthritis, Knee
- Obstructive Sleep Apnea
Interventions
RetatrutideDrug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Body WeightTime frame: Baseline, Week 80
- Change from Baseline in Apnea-Hypopnea Index (AHI) Events Per Hour for GSA1 SubsetTime frame: Baseline, Week 80
- Change from Baseline in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score for GOA1 SubsetTime frame: Baseline, Week 80
- Percent Change from Baseline in Body Weight in Participants in Extension SubsetTime frame: Baseline, Week 104
Locations
134 sites in 12 countries. Site status is shown where the registry gives one.
Central Phoenix Medical Clinic
Phoenix, Arizona
Arizona Research Center
Phoenix, Arizona
Medical Investigations
Little Rock, Arkansas
Neuro-Pain Medical Center
Fresno, California
Valley Research
Fresno, California
Artemis Institute for Clinical Research
San Diego, California
University of Colorado Anschutz Medical Campus
Aurora, Colorado
Yale University School of Medicine
New Haven, Connecticut
Chase Medical Research, LLC
Waterbury, Connecticut
Teradan Clinical Trials, LLC
Brandon, Florida
Suncoast Research Group
Miami, Florida
New Horizon Research Center
Miami, Florida
Clinical Neuroscience Solutions
Orlando, Florida
Progressive Medical Research
Port Orange, Florida
NeuroTrials Research Inc
Atlanta, Georgia
North Georgia Clinical Research
Woodstock, Georgia
East-West Medical Research Institute
Honolulu, Hawaii
Northwestern University
Chicago, Illinois
Central Illinois Diabetes and Clinical Research a Division of Prairie Education and Research Cooperative
Springfield, Illinois
Brengle Family Medicine
Indianapolis, Indiana
Cotton O'Neil Diabetes & Endocrinology
Topeka, Kansas
MedVadis Research Corporation
Waltham, Massachusetts
Great Lakes Research Group, Inc.
Bay City, Michigan
StudyMetrix Research
City of Saint Peters, Missouri
Clinvest Research LLC
Springfield, Missouri
Palm Research Center Tenaya
Las Vegas, Nevada
Rochester Clinical Research, LLC
Rochester, New York
Carteret Medical Group
Morehead City, North Carolina
Trial Management Associates - Wilmington - Floral Parkway
Wilmington, North Carolina
Lillestol Research
Fargo, North Dakota
Altoona Center For Clinical Research
Duncansville, Pennsylvania
Tribe Clinical Research, LLC
Greenville, South Carolina
Tribe Clinical Research - Spartanburg
Spartanburg, South Carolina
Vanderbilt Health One Hundred Oaks
Nashville, Tennessee
FutureSearch Trials of Neurology
Austin, Texas
Juno Research
Houston, Texas
Advanced Research Institute
Ogden, Utah
Northwest Clinical Research Center
Bellevue, Washington
Rainier Clinical Research Center
Renton, Washington
Emeritus Research
Botany, New South Wales, Australia
Showing 40 of 134 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.